180KShares reported
From a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
PFE · NYSE · Pharmaceuticals
From a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
Institutions reporting a stake, Q2 2026
2,818
-136 vs Q1 2026
Share of stock reported
67.2%
3.83B of 5.7B shares outstanding
Change vs Q1 2026
-815K shares
115 new positions, 237 positions closed
Reported in 13F filings, which cover managers over $100M and include double counting. A 13F shows holdings on the last day of the quarter, not when shares were bought or sold. Change counts the 2,776 managers that reported both quarters.
Source: SEC Form 13F data sets, every filer, common stock only (options and bonds left out); 52 managers also reported puts and 60 managers calls. Amendments are applied; lines whose value was filed in thousands are scaled, and lines whose shares and value disagree are left out.